Editorial Team
Advisory Editor-in-Chief
Cure Kids Chair of Paediatric Research at UOC, University of Otago, New Zealand
Editor-in-Chief
State Key Laboratory of Epigenetic Regulation and Intervention, IBP, Chinese Academy of Sciences, China
Research Interests: Immunometabolism
Xingxiang Pu
Hunan Cancer Hospital, Changsha, China
Executive Editor
Committee Member of the IASLC Rare Tumors Committee (2023-2025)
Hangzhou Institute of Medicine , Chinese Academy of Sciences, China
Associate Editors
University of Cambridge, UK
Gannan Medical University; HaploX Biotechnology, China
Editorial Board Members
Ke Wang, Jiangsu institute of nuclear medicine, China
Hong Zhu, Zhejiang University, China
Jinrong Zheng, The First Hospital of Hebei Medical University, China
Shuai Ren, Department of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, China
Jincheng Wang, Hokkaido University, Japan
Bhaskar Roy, Hangzhou Institute of Medicine (HIM), Chinese Academy of Science, China
Shaogui Wan, Gannan Medical University, China
Rui Dong, Children‘s Hospital of Fudan University, China
Fares Al-Shargie, Rutgers University, United States
Andee Dzulkarnaen Zakaria, Department of Surgery, School of Medical Sciences & USM Specialist Hospital, Universiti Sains Malaysia, Malaysia
Jones Gyamfi, Teesside University, United Kingdom
Zimu Wu, Monash University, Australia
Wu, Hao, institute of systemimmunology， Würzburg University, Germany
Wai Chin Chong, Children’s National Hospital, United States
Manmeet Rawat, Penn State College of Medicine, United States
Sheila Spada, Tumor immunology and Immunotherpy Unit, Regina Elena National Cancer Institute , Italy
MUSTAFA ŞAHİN, Ankara University,Türkiy
Hsien-Yuan Lane, China Medical University
Oleg V. Tcheremissine, Psychiatry and Behavioral Medicine, Wake Forest University, United States
Monjur Ahmed, Thomas Jefferson University ,United States
